AERIE PHARMACEUTICALS INC Quarterly Income Tax Expense (Benefit) in USD from Q2 2014 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Aerie Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2014 to Q3 2022.
  • Aerie Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $95K, a 63.8% increase year-over-year.
  • Aerie Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2022 was $1.32M, a 75.5% decline year-over-year.
  • Aerie Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was $593K, a 88.7% decline from 2020.
  • Aerie Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2020 was $5.25M.
  • Aerie Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2019 was -$90K, a 3100% decline from 2018.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $1.32M $95K +$37K +63.8% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $1.29M $48K +$30K +167% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $1.26M $693K +$662K +2135% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $593K $486K -$4.79M -90.8% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-25
Q3 2021 $5.39M $58K +$58K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $5.33M $18K +$18K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $5.31M $31K +$64K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $5.25M $5.28M +$5.28M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-25
Q3 2020 -$33K $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$33K $0 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$33K -$33K +$57K +63.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$90K $0 $0 Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 -$90K $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$90K $0 -$3K -100% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$87K -$90K -$90K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $3K $0 +$1.9M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 -$1.9M $0 -$49K -100% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$1.85M $3K -$44K -93.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$1.8M $0 -$46K -100% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$1.76M -$1.9M -$1.96M -3215% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $203K $49K +$10K +25.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $193K $47K $0 0% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $193K $46K $0 0% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $193K $61K +$146K Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $47K $39K -$33K -45.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $80K $47K -$105K -69.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $185K $46K +$46K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $139K -$85K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $72K +$72K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $152K +$152K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q3 2014 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $0 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.